
ArchiMed's Piccoli joins Keensight as senior analyst
David Piccoli, a co-founder and senior analyst at healthcare GP ArchiMed, has been hired for the same role by French growth capital investor Keensight Capital.
Piccoli's private equity career began at Cordusio Società Fiduciaria, where he worked on the regularisation of Italian funds between April and July 2010.
In January 2011, he was recruited as a healthcare, social media and renewables analyst by Hamilton Ventures. In July 2012, he joined Ardian's small-cap team and was involved in fundraising for the GP's third expansion fund.
In January 2013, he began working as a healthcare analyst at listed GP 3i Group. In mid-2014, when 3i's healthcare team spun out and rebranded as ArchiMed, Piccoli joined the new firm alongside fellow co-founders Denis Ribon, Vincent Guillaumot and Cédric Berger.
Last May, Alexandre Carrot and Guillaume Lefebvre, who had both joined Keensight in June 2014, were promoted to chief financial officer and associate, respectively.
Three months later, Jaana Grüter, formerly an analyst at Rothschild's Five Arrows Principal Investments team, left the firm to join Keensight as an analyst.
Having made a 12x money multiple on the sale of spinal implant designer LDR Medical, Keensight currently holds a stake in a single healthcare company, Menix Group. The business, a prostheses designer owned alongside LBO Partners and Turenne, bolted on peer OneOrtho-Medical last summer.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds